Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

361 results

ISCHEMIA: balancing the risks and benefits of invasive procedures in stable ischemic heart disease patients

16 Apr 2020

In this expert interview, Dejan Milasinovic asks Francesco Burzotta to provide his take on the ISCHEMIA trial.

Francesco Burzotta

Author

Francesco Burzotta
Dejan Milasinovic

Author

Dejan Milasinovic
Selection & management in the ISCHEMIA Trial

ISCHEMIA trial : what's new for stable ischemic heart disease patients ?

09 Apr 2020

The ISCHEMIA trial was designed to evaluate the clinical impact of systematic invasive management in patients with stable ischemic heart disease and significant inducible ischemia. Read this review by guest expert reviewers Francesco Burzotta and Carlo Trani.

Francesco Burzotta

Reviewer

Francesco Burzotta
C. Trani

Reviewer

Carlo Trani
ISCHEMIA trial : what's new for stable ischemic heart disease patients ?

Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study

26 Mar 2020

The objective of this analysis was to investigate the potential benefits of FKI in bifurcations treated with new generation ultrathin stents using a 1- or 2-stent technique.

Reviewer

Ali Nazmi Calik
Panagiotis Xaplanteris

Reviewer

Panagiotis Xaplanteris
Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

Fractional flow reserve or optical coherence tomography to guide management of angiographically intermediate coronary stenosis: a single-center trial

21 Jan 2020

This study aimed at comparing the effects of fractional flow reserve- vs. optical coherence tomography-guided treatment of angiographically intermediate coronary stenosis.

Dejan Milasinovic

Reviewer

Dejan Milasinovic
Fractional flow reserve or optical coherence tomography to guide management of angiographically intermediate coronary stenosis: a single-center trial

Best of PCRonline in 2019

13 Jan 2020

Thank you to the thousands of cardiologists and healthcare professionals whose contribution to the website provides the community with a valuable, free resource of education in cardiovascular interventions - this embodies the By and For that sets PCRonline apart! Thanks to you, over half a million...

Best of PCRonline in 2019

Using physiology to determine coronary intervention in Stable Coronary Artery Disease – FFR, iFR and QFR

06 Jan 2020 – From AICT-AsiaPCR 2020

Consult this session to learn more about the role of FFR in stable coronary artery disease intervention, the common pitfalls and tips & tricks in performing FFR measurement, as well as the emerging role of QFR in assessing the significance of intermediate stenosis.

Using physiology to determine coronary intervention in Stable CAD – FFR, iFR and QFR

Determining the predominant lesion in patients with severe aortic stenosis and coronary stenoses: A multicenter study using intracoronary pressure and flow

20 Dec 2019

Concomitant coronary artery disease (CAD) is frequently found in patients with severe aortic stenosis (AS) undergoing treatment with transcatheter aortic valve implantation (TAVI).

Nicola Ryan

Reviewer

Nicola Ryan
Determining the predominant lesion in patients with severe aortic stenosis and coronary stenoses

One-year outcomes of angina management guided by invasive coronary function testing (CorMicA)

27 Nov 2019

CorMicA was a randomised control trial comparing medical therapy guided by invasive coronary function testing (CFR, IMR and acetylcholine provocation) versus standard care in 151 patients with symptoms and/or signs of ischaemia with no obstructive coronary artery disease (INOCA).

Nicola Ryan

Reviewer

Nicola Ryan
Dejan Milasinovic

Reviewer

Dejan Milasinovic
One-year outcomes of angina management guided by invasive coronary function testing (CorMicA)

Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting

10 Nov 2019

One of the most discussed limitations of GLOBAL-LEADER is the lack of event adjudication so that the rate of MI, bleeding or stent thrombosis between the two groups were unknown. In this study, events were adjudicated in those patients from the 20 top-enrolling participating sites.

Reviewer

Salvatore Brugaletta
Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting